NovoCure

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NovoCure and other ETFs, options, and stocks.

About NVCR

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division.

CEO

Ashley Cordova

CEOAshley Cordova

Employees

1,488

Employees1,488

Headquarters

St. Helier, Jersey

HeadquartersSt. Helier, Jersey

Founded

2000

Founded2000

Employees

1,488

Employees1,488

NVCR Key Statistics

Market cap

1.38B

Market cap1.38B

Price-Earnings ratio

-7.90

Price-Earnings ratio-7.90

Dividend yield

—

Dividend yield—

Average volume

1.23M

Average volume1.23M

High today

$12.47

High today$12.47

Low today

$11.75

Low today$11.75

Open price

$12.06

Open price$12.06

Volume

1.01M

Volume1.01M

52 Week high

$34.13

52 Week high$34.13

52 Week low

$10.87

52 Week low$10.87

NVCR News

Simply Wall St 5d

NovoCure: How FDA Filing for TTFields in Pancreatic Cancer Shapes the Stock’s Valuation Outlook

If you have been keeping tabs on NovoCure (NVCR), you probably noticed the latest surge in conversation: the company has just filed a premarket approval applica...

TipRanks 5d

Novocure announces coverage for Tumor Treating Fields therapy in Spain

Novocure (NVCR) announced that Spain’s Ministry of Health has made Tumor Treating Fields therapy available through the Spanish National Health System for the tr...

Analyst ratings

63%

of 8 ratings

Buy

62.5%

Hold

37.5%

Sell

People also own

Based on the portfolios of people who own NVCR. This list is generated using Robinhood data, and it’s not a recommendation.